Linked Life Data

21168205

Source:http://linkedlifedata.com/resource/pubmed/id/21168205

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2011-1-24
pubmed:abstractText
Preeclampsia is one of the leading causes for maternal and fetal morbidity. Attempts to prevent preeclampsia have already been made using low-dose aspirin, low-molecular-weight heparin (LMWH), and calcium supplementation. Magnesium sulphate is used at the time of disease to prevent eclampsia. Here we investigated the effect of these agents on PP13 release from placental explants.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1532-3102
pubmed:author
pubmed:copyrightInfo
Copyright © 2010 Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
32 Suppl
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S55-64
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants.
pubmed:affiliation
Diagnostic Technologies Ltd., 20692 Yoqneam, Israel.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Evaluation Studies